Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Development of the integrated fish endocrine disruptor test-Part B: Implementation of thyroid-related endpoints.
Integr Environ Assess Manag. 2024 May;20(3):830-845. doi: 10.1002/ieam.4828. Epub 2023 Aug 29.
Integr Environ Assess Manag. 2024.
PMID: 37578010
Development of the integrated fish endocrine disruptor test (iFEDT)-Part A: Merging of existing fish test guidelines.
Pannetier P, Gölz L, Pissarreira Mendes Fagundes MT, Knörr S, Behnstedt L, Coordes S, Matthiessen P, Morthorst JE, Vergauwen L, Knapen D, Holbech H, Braunbeck T, Baumann L.
Pannetier P, et al.
Integr Environ Assess Manag. 2024 May;20(3):817-829. doi: 10.1002/ieam.4819. Epub 2023 Aug 22.
Integr Environ Assess Manag. 2024.
PMID: 37483114
Item in Clipboard
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.
Ratliff M, Karimian-Jazi K, Hoffmann DC, Rauschenbach L, Simon M, Hai L, Mandelbaum H, Schubert MC, Kessler T, Uhlig S, Dominguez Azorin D, Jung E, Osswald M, Solecki G, Maros ME, Venkataramani V, Glas M, Etminan N, Scheffler B, Wick W, Winkler F.
Ratliff M, et al.
Neuro Oncol. 2023 Dec 8;25(12):2150-2162. doi: 10.1093/neuonc/noad109.
Neuro Oncol. 2023.
PMID: 37335907
Item in Clipboard
Cite
Cite